Comment on 'The effect of lacosamide in peripheral neuropathic pain: A randomized, double-blind, placebo-controlled, phenotype-stratified trial' by Carmland et al
- PMID: 37725444
- DOI: 10.1002/ejp.2186
Comment on 'The effect of lacosamide in peripheral neuropathic pain: A randomized, double-blind, placebo-controlled, phenotype-stratified trial' by Carmland et al
Comment on
-
The effect of lacosamide in peripheral neuropathic pain: A randomized, double-blind, placebo-controlled, phenotype-stratified trial.Eur J Pain. 2024 Jan;28(1):105-119. doi: 10.1002/ejp.2165. Epub 2023 Aug 11. Eur J Pain. 2024. PMID: 37565715 Clinical Trial.
References
REFERENCES
-
- Alcántara Montero, A. (2022). Off-label use of lacosamide: An alternative for the treatment of neuropathic pain. Headache, 62(9), 1239-1240. https://doi.org/10.1111/head.14399
-
- Alcántara Montero, A., & Sánchez Carnerero, C. I. (2016). Lacosamide and neuropathic pain: A review. Revista de Neurologia, 62(5), 223-229.
-
- Carmland, M. E., Kreutzfeldt, M. D., Holbech, J. V., Brask-Thomsen, P. K., Krøigård, T., Hansen, P. N., Tankisi, H., Jensen, T. S., Bach, F. W., Sindrup, S. H., & Finnerup, N. B. (2024). The effect of lacosamide in peripheral neuropathic pain: A randomized, double-blind, placebo-controlled, phenotype-stratified trial. European Journal of Pain, 28(1), 105-119. https://doi.org/10.1002/ejp.2165
-
- Muñoz-Vendrell, A., Tena-Cucala, R., Campoy, S., García-Parra, B., Prat, J., Martínez-Yélamos, S., & Huerta-Villanueva, M. (2023). Oral lacosamide for the treatment of refractory trigeminal neuralgia: A retrospective analysis of 86 cases. Headache, 63(4), 559-564. https://doi.org/10.1111/head.14505